Update Venetoclax in CLL
Acalabrutinib
Obinutuzumab
Zanubrutinib
(Update) Acalabrutinib in CLL and MCL
UpToDate
NCCN Guidelines for Patients for CLL
NCCN COVID-19 Resources Page
Leukemia & Lymphoma Society